Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

NCT03988855 is registered in ClinicalTrials.gov with Deinove as lead sponsor.

NCT NCT03988855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03988855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
Lead sponsor
Deinove
Phase
Phase 2
Overall status
Unknown status
Start date
August 2, 2019
Completion date
December 31, 2022
Enrollment
40 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile (c. difficile)